308 related articles for article (PubMed ID: 31200490)
1. Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery.
Tai W
Molecules; 2019 Jun; 24(12):. PubMed ID: 31200490
[TBL] [Abstract][Full Text] [Related]
2. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.
Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C
Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280
[TBL] [Abstract][Full Text] [Related]
3. SiRNA drug delivery by biodegradable polymeric nanoparticles.
Yuan X; Li L; Rathinavelu A; Hao J; Narasimhan M; He M; Heitlage V; Tam L; Viqar S; Salehi M
J Nanosci Nanotechnol; 2006; 6(9-10):2821-8. PubMed ID: 17048488
[TBL] [Abstract][Full Text] [Related]
4. siRNA conjugate delivery systems.
Jeong JH; Mok H; Oh YK; Park TG
Bioconjug Chem; 2009 Jan; 20(1):5-14. PubMed ID: 19053311
[TBL] [Abstract][Full Text] [Related]
5. Advances in targeted delivery of small interfering RNA using simple bioconjugates.
Nielsen C; Kjems J; Sørensen KR; Engelholm LH; Behrendt N
Expert Opin Drug Deliv; 2014 May; 11(5):791-822. PubMed ID: 24669756
[TBL] [Abstract][Full Text] [Related]
6. Optimized fluorodendrimer-incorporated hybrid lipid-polymer nanoparticles for efficient siRNA delivery.
Xiong Q; Li Y; Zhou K; Chen P; Guo H; Chen L; Ding J; Song T; Shi J
Biomater Sci; 2020 Feb; 8(3):758-762. PubMed ID: 31965126
[TBL] [Abstract][Full Text] [Related]
7. Conjugation of palmitic acid improves potency and longevity of siRNA delivered via endosomolytic polymer nanoparticles.
Sarett SM; Kilchrist KV; Miteva M; Duvall CL
J Biomed Mater Res A; 2015 Sep; 103(9):3107-16. PubMed ID: 25641816
[TBL] [Abstract][Full Text] [Related]
8. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model.
Jansen MAA; Klausen LH; Thanki K; Lyngsø J; Skov Pedersen J; Franzyk H; Nielsen HM; van Eden W; Dong M; Broere F; Foged C; Zeng X
Eur J Pharm Biopharm; 2019 Sep; 142():38-48. PubMed ID: 31199978
[TBL] [Abstract][Full Text] [Related]
9. Polymeric systems as nanodevices for siRNA delivery.
Tiera MJ; Shi Q; Barbosa HF; Fernandes JC
Curr Gene Ther; 2013 Oct; 13(5):358-69. PubMed ID: 24369060
[TBL] [Abstract][Full Text] [Related]
10. The Use of Star Polymer Nanoparticles for the Delivery of siRNA to Mouse Orthotopic Pancreatic Tumor Models.
McCarroll JA; Sharbeen G; Kavallaris M; Phillips PA
Methods Mol Biol; 2019; 1974():329-353. PubMed ID: 31099013
[TBL] [Abstract][Full Text] [Related]
11. Tumor Selective Silencing Using an RNAi-Conjugated Polymeric Nanopharmaceutical.
Svenson S; Case RI; Cole RO; Hwang J; Kabir SR; Lazarus D; Lim Soo P; Ng PS; Peters C; Shum P; Sweryda-Krawiec B; Tripathi S; van der Poll D; Eliasof S
Mol Pharm; 2016 Mar; 13(3):737-47. PubMed ID: 26835715
[TBL] [Abstract][Full Text] [Related]
12. Chemistry and formulations for siRNA therapeutics.
Gallas A; Alexander C; Davies MC; Puri S; Allen S
Chem Soc Rev; 2013 Oct; 42(20):7983-97. PubMed ID: 23857524
[TBL] [Abstract][Full Text] [Related]
13. Acute in vivo toxicity mitigation of PEI-coated maghemite nanoparticles using controlled oxidation and surface modifications toward siRNA delivery.
Israel LL; Lellouche E; Ostrovsky S; Yarmiayev V; Bechor M; Michaeli S; Lellouche JP
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15240-55. PubMed ID: 26120905
[TBL] [Abstract][Full Text] [Related]
14. Small-interfering RNA (siRNA)-based functional micro- and nanostructures for efficient and selective gene silencing.
Lee SH; Chung BH; Park TG; Nam YS; Mok H
Acc Chem Res; 2012 Jul; 45(7):1014-25. PubMed ID: 22413937
[TBL] [Abstract][Full Text] [Related]
15. Smart siRNA delivery systems based on polymeric nanoassemblies and nanoparticles.
Tamura A; Nagasaki Y
Nanomedicine (Lond); 2010 Sep; 5(7):1089-102. PubMed ID: 20874023
[TBL] [Abstract][Full Text] [Related]
16. Strategies for in vivo siRNA delivery in cancer.
Sanguino A; Lopez-Berestein G; Sood AK
Mini Rev Med Chem; 2008 Mar; 8(3):248-55. PubMed ID: 18336345
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of polymers for short interfering RNA delivery in vascular smooth muscle cells.
Bools LM; Fisher RK; Grandas OH; Kirkpatrick SS; Arnold JD; Goldman MH; Freeman MB; Mountain DJ
J Surg Res; 2015 Nov; 199(1):266-73. PubMed ID: 26272685
[TBL] [Abstract][Full Text] [Related]
18. Surface Design Options in Polymer- and Lipid-Based siRNA Nanoparticles Using Antibodies.
Gabel M; Knauss A; Fischer D; Neurath MF; Weigmann B
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430411
[TBL] [Abstract][Full Text] [Related]
19. Polymeric nanoparticles for siRNA delivery and gene silencing.
Patil Y; Panyam J
Int J Pharm; 2009 Feb; 367(1-2):195-203. PubMed ID: 18940242
[TBL] [Abstract][Full Text] [Related]
20. Gold nanostar-polymer hybrids for siRNA delivery: Polymer design towards colloidal stability and in vitro studies on breast cancer cells.
Sardo C; Bassi B; Craparo EF; Scialabba C; Cabrini E; Dacarro G; D'Agostino A; Taglietti A; Giammona G; Pallavicini P; Cavallaro G
Int J Pharm; 2017 Mar; 519(1-2):113-124. PubMed ID: 28093325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]